Screener
BioCryst Pharmaceuticals BCRX Business Segments — Cost of product sales
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| License and other revenues | 60,737 | 923 | 65,749 | 2,670 |
| Total revenues | 218,250 | 163,353 | 374,663 | 308,887 |
| Expenses: | ||||
| Cost of product sales | 3,840 | 2,798 | 9,217 | 7,366 |
| Acquired in-process research and development | — | — | 697,761 | — |
| Research and development | 51,969 | 43,386 | 112,288 | 80,656 |
| Selling, general and administrative | 63,976 | 87,383 | 158,530 | 169,852 |
| Total operating expenses | 119,785 | 133,567 | 977,796 | 257,874 |
Item 1. Financial Statements (Unaudited):
FAQ
- What is BioCryst Pharmaceuticals's business segments — cost of product sales?
- BioCryst Pharmaceuticals (BCRX) reported business segments — cost of product sales of $3.84M in Q2 2026.
- How has BioCryst Pharmaceuticals's business segments — cost of product sales changed year-over-year?
- BioCryst Pharmaceuticals's business segments — cost of product sales increased by 37.2% year-over-year, from $2.8M to $3.84M.
- What is the long-term trend for BioCryst Pharmaceuticals's business segments — cost of product sales?
- Over 3 years (2022 to 2025), BioCryst Pharmaceuticals's business segments — cost of product sales has grown at a 43.9% compound annual growth rate (CAGR), from $6.41M to $19.08M.
- What does business segments — cost of product sales mean?
- Includes the direct costs associated with manufacturing, packaging, and distributing the products sold by the segment. Monitoring this helps evaluate the segment's production efficiency and the impact of manufacturing scale on gross margins.
Ask your AI about BioCryst Pharmaceuticals's business segments — cost of product sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude